RSS-Feed abonnieren
DOI: 10.1055/s-0035-1549966
Socioeconomic Deprivation Independently Predicts Painful Diabetic Neuropathy in Type 2 Diabetes
Publikationsverlauf
received 31. Dezember 2014
first decision 08. April 2015
accepted 22. April 2015
Publikationsdatum:
11. Juni 2015 (online)
![](https://www.thieme-connect.de/media/eced/201507/lookinside/thumbnails/12-2014-0469-dia_10-1055-s-0035-1549966-1.jpg)
Abstract
Objective: Painful peripheral neuropathy in people with type 2 diabetes is a disabling complication. We explored associations of this condition with socioeconomic deprivation.
Research Design and Methods: The Townsend index of socioeconomic deprivation was examined in the pseudonymised GP records of 15388 (44.1% female) individuals with type 2 diabetes in the Cheshire county of England, and related to prevalence of drug treated painful diabetic neuropathy. We also analysed prescription trends with respect to pharmacotherapy for neuropathy pain relief.
Results: Treatment for neuropathic pain was initiated in 3 266 (21.2%) of patients. Those on treatment were older [68.2 (95% CI 67.8–68.7) vs. 66.6 (66.4–66.8) years] than those not on treatment. There was no difference in HbA1c (7%, 55 mmol/mol).
There were significant differences between the groups for the Townsend deprivation index, with a greater proportion (30.6% vs. 22.8% of patients with treated neuropathic pain) having a score of ≥1 (Χ2=83.9, p<0.0001).
Multivariate logistic regression analyses indicated that each unit increment in the Townsend index was associated with an 6% increased odds of requiring neuropathic pain treatment [odds ratio (95%CI) 1.06 (1.05–1.08), p<0.0001] independent of 5 year age band, BMI, gender, systolic BP, eGFR, HbA1C and total cholesterol.
Conclusions: In this study using pseudonymised clinical records, a higher level of socioeconomic deprivation seemingly may predispose to severe neuropathic pain in diabetes requiring pharmacological intervention. Targeted allocation of healthcare resources to this group may offer clinical benefits.
-
References
- 1 Young MJ, Boulton AJ, MacLeod AF et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-154
- 2 Pop-Busui R, Lu J, Lopes N et al. and Investigators BD. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J Peripher Nerv Syst 2009; 14: 1-113
- 3 Abbott CA, Malik RA, van Ross ERE et al. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care 2011; 34: 2220-2224
- 4 Tesfaye S, Stevens LK, Stephenson JM et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1377-1384
- 5 Collier A, Ghosh S, Hair M et al. Impact of socioeconomic status and gender on glycaemic control, cardiovascular risk factors and diabetes complications in type 1 and 2 diabetes: A population based analysis from a Scottish region. Diabetes Metab 2014; pii: S1262-363600143-8
- 6 Perna L, Mielck A, Lacruz ME et al. The association between resilience and diabetic neuropathy by socioeconomic position: Cross-sectional findings from the KORA-Age study. J Health Psychol 2013; (epub ahead of print)
- 7 Secrest AM, Costacou T, Gutelius B et al. Associations between socioeconomic status and major complications in type 1 diabetes: the Pittsburgh epidemiology of diabetes complication (EDC) Study. Ann Epidemiol 2011; 21: 374-381
- 8 Millett C, Car J, Eldred D et al. Diabetes prevalence, process of care and outcomes in relation to practice size, caseload and deprivation: national cross-sectional study in primary care. J R Soc Med 2007; 100: 275-283
- 9 Walker JJ, Livingstone SJ, Colhoun HM et al. and Scottish Diabetes Research Network Epidemiology G . Effect of socioeconomic status on mortality among people with type 2 diabetes: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care 2011; 34: 1127-1132
- 10 Scanlon PH, Carter SC, Foy C et al. Diabetic retinopathy and socioeconomic deprivation in Gloucestershire. J Med Screen 2008; 15: 118-121
- 11 All Party Parliamentary Group and Diabetes UK. Diabetes and the disadvantaged: reducing health inequalities in the UK. [Internet] 2006 Available from http://www.diabetes.org.uk/Documents/Reports/Diabetes_disadvantaged_Nov2006.pdf Accessed 28 October 2013
- 12 Ince P, Kendrick D, Game F et al. The association between baseline characteristics and the outcome of foot lesions in a UK population with diabetes. Diabetic Medicine 2007; 24: 977-981
- 13 Bihan H, Laurent S, Sass C et al. Association among individual deprivation, glycemic control, and diabetes complications: the EPICES score. Diabetes Care 2005; 28: 2680-2685
- 14 Anderson SG, Malipatil NS, Roberts H et al. Socioeconomic deprivation independently predicts symptomatic painful diabetic neuropathy in type 1 diabetes. Prim Care Diabetes 2014; 8: 65-69
- 15 Philimore P, Beattie A, Townsend P. Widening inequality of health in northern England, 1981–91. BMJ 1994; 308: 1125-1128
- 16 Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine 1999; 130: 461-470
- 17 Hosmer DW, Hjort NL. Goodness-of-fit processes for logistic regression: simulation results. Stat Med 2002; 21: 2723-2738
- 18 Franks P, Fiscella K, Beckett L et al. Effects of patient and physician practice socioeconomic status on the health care of privately insured managed care patients. Medical Care 2003; 41: 842-852
- 19 Sen HM, Sen H, Aşık M et al. The Importance of Education in Diabetic Foot Care of Patients with Diabetic Neuropathy. Exp Clin Endocrinol Diabetes 2015; 123: 178-181
- 20 Preciado-Puga MC, Malacara JM, Fajardo-Araujo ME et al. Markers of the progression of complications in patients with type 2 diabetes: a one-year longitudinal study. Exp Clin Endocrinol Diabetes 2014; 122: 484-490
- 21 Ziegler D, Keller J, Maier C et al. Diabetic neuropathy. Exp Clin Endocrinol Diabetes 2014; 122: 406-415
- 22 National Institute of Health and Clinical Excellence. Neuropathic pain-pharmacological management (CG173). [Internet] 2013 Available from http://guidance.nice.org.uk/CG173 Accessed 26 Dec 2013
- 23 Gooch C, Podwall D. The diabetic neuropathies. Neurologist 2004; 10: 311-322
- 24 Office of National Statistics. 2011 Census: KS201 UK Ethnic Group, local authorities in the United Kingdom. [Internet] 2013 Available from http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-327143 Accessed 26 Dec 2013